Condition: Oestrogen receptor positive breast cancer
rs140538758
in
CBFB
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs2981579
in
FGFR2
gene and
Oestrogen receptor positive breast cancer
PMID 28864454
2017 Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.
rs6938753
in
LINC02521;LINC01600
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs12998806
in
LOC105373874;LOC101928278
gene and
Oestrogen receptor positive breast cancer
PMID 28171663
2016 In addition, we confirmed SNP rs10069690 was the best indicator for ER-negative breast cancer at 5p15.33 (OR = 1.30; P = 2.4 × 10 − 10) and identified
rs12998806
as the best indicator for
ER-positive breast cancer
at 2q35 (OR = 1.34; P = 2.2 × 10 − 8) for women of African ancestry.
rs11251942
in
LOC105376360
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs62235635
in
PITPNB;TTC28-AS1;MIR3199-2
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs12938141
in
RAP1GAP2
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs7082321
in
SFMBT2
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs73370840
in
SLC19A1;COL18A1
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.
rs79116769
in
SLC25A4
gene and
Oestrogen receptor positive breast cancer
PMID 30787463
2019 Genome-wide association study of germline variants and breast cancer-specific mortality.